Summary
The antidiabetic activity of Momordica charantia L. (Cucurbitaceae) was inves tigated in KK-Ay mice, an animal model with type 2 diabetes with hyperinsulinemia. The water extract of the fruit of Momordica charantia L. (MC) reduced the blood glucose of KK-Ay mice 3 weeks after oral administration (p<0.01) and also significantly lowered the serum insulin of KK-Ay mice under similar conditions (p<0.01). However, MC did not affect the blood glucose in normal mice. MC-treated KK-Ay mice blood glucose significantly decreased in an insulin tolerance test. Moreover, the muscle content of facilitative glucose transporter isoform 4 (GLUT4) protein content in the plasma membrane fraction from muscle signifi cantly increased in the orally MC-treated mice when compared with that of the controls (p<0.01). These results suggest that the antidiabetic effect of MC is derived, at least in part, from a decrease in insulin resistance because of the increase of GLUT4 protein content in the plasma membrane of the muscle. Key Words hypoglycemic effect, Momordica charantia, Cucurbitaceae, insulin resistance, GLUT4
Despite much progress in the management of dia betes mellitus by synthetic drugs, the search for indige nous natural antidiabetic agents is ongoing. The plant kingdom is a wide field in which to look for effective oral hypoglycemics. More than 400 species have been re ported to display hypoglycemic effects, but only a few have been investigated (1) (2) (3) .
In Okinawa, where many people live to an advanced age, the inhabitants eat fruits of the Momordica charan tia L. The fruits of the Momordica charantia L. (Cucur bitaceae) (named Nigauri in Japanese), a plant widely used in traditional medicine as an antidiabetic agent, has been shown to lower blood glucose in laboratory animals (4-10). However, an adequate characterization of this effect has yet to be made. So far, experiments have been performed on a type 1 diabetes model ani mal, but no study has been performed on genetically type 2 diabetes models.
Glucose transport across the plasma membrane is mediated by carrier proteins termed glucose trans porters (11, 12) . Recent cDNA cloning has demon strated that the facilitative glucose transporters com prise a family of structurally related proteins with differ ing tissue distribution (13) . The gene expression and protein content of glucose transporters have been found to be altered under pathological conditions such as dia betes mellitus (13) (14) (15) .
In the present study, we have examined the effect of Momordica charantia L. on blood glucose and the effect * To whom correspondence should be addressed . MC-treated KK-Ay mice also had lower blood glucose in the insulin tolerance test and hyperinsulinemia was improved. Insulin (0.5U/kg)-treated KK-Ay mice had no lower blood glucose because of insulin resistance in the peripheral tissues, suggesting that MC lessens in sulin resistance. Higashino et al. reported that MC de creased the blood glucose in streptozotocin-induced dia betic rats, an animal model of type 1 diabetes, and sug gested that the hypoglycemic mechanism of MC was due to a decrease in glucose absorption in the small in testine (7). Day et al. reported that MC decreased blood glucose in mice with no changes in insulin secretion and suggested that the hypoglycemic mechanism was due to an increase of the glucose utilization in periph eral tissues (6) . From these findings, it seems very likely that the hypoglycemic mechanism of MC is due to the reduction of insulin resistance by decreasing the glu cose absorption in the small intestine. However, our data indicated that MC decreased the blood glucose in normal mice. Moreover, MC did not affect the blood glu cose in a glucose tolerance test after repeated adminis tration. It is possible to directly activate the insulin re ceptor in peripheral tissues and thereafter to increase the glucose uptake.
Furthermore, we examined the effect of MC on GLUT4 glucose transporter in mouse muscle, since it has been reported that GLUT4 plays a crucial role in the muscle process of glucose uptake. MC increased GLUT4 protein content of muscle in KK-Ay mice. It is known that GLUT4 and GLUT 1 are present in skeletal muscle. However, MC did not affect GLUT1 protein content in skeletal muscle (data not shown). From these findings, it is very likely that the hypoglycemic effect of MC is de rived, at least in part, from the decrease in insulin resist ance, presumably because of the increase of GLUT4 pro tein content in total muscle membrane.
As for the hypoglycemic compounds of MC, Aui et al. reported that MC contained nonsapogenin, which may have contributed to the reduction of blood glucose in streptozotocin-induced diabetic rats (9). Lolkar et al. re ported that the hypoglycemic principle was charantin (5) . In the present study, these compounds could be re lated to the antidiabetic activity.
Further study would show how MC could become a useful drug in the treatment of diabetes through this unique therapeutic mechanism. The above experimen tal results suggest that the antidiabetic activity of MC supports the traditional medical use of type 2 diabetes.
